Dr. Joseph Longo received his B.Sc. from the Honours Molecular Biology and Genetics Program at McMaster University (Hamilton, ON, Canada), after which he completed his Ph.D. in the Department of Medical Biophysics at the University of Toronto (Toronto, ON, Canada). Dr. Longo’s Ph.D. research focused on the role of the mevalonate pathway in cancer, and how drugs that target this metabolic pathway, such as statins, can be repurposed to treat specific cancers. To that end, he has extensive experience with evaluating experimental therapeutics in vitro and in vivo using a range of cancer models, including cell lines, patient-derived xenografts and primary clinical specimens. In 2020, he joined the lab of Dr. Russell Jones as a postdoctoral fellow to continue his research on cancer metabolism.